Not available
Quote | Collegium Pharmaceutical Inc. (NASDAQ:COLL)
Last: | $31.41 |
---|---|
Change Percent: | -0.32% |
Open: | $31.46 |
Close: | $31.51 |
High: | $31.47 |
Low: | $31.15 |
Volume: | 21,204 |
Last Trade Date Time: | 06/26/2024 03:00:00 am |
News | Collegium Pharmaceutical Inc. (NASDAQ:COLL)
2024-06-24 12:56:10 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fundamentally, the biotechnology sphere enjoys a powerful catalyst: wealth without health means nothing. Yes, it’s important to save money and invest for the future. At the same time, in...
2024-06-16 10:23:34 ET Summary This monthly article series provides a dashboard with aggregate industry metrics in healthcare. The healthcare sector is moderately overvalued relative to 11-year averages, and healthcare providers are the least overvalued subsector. Focus on IHF...
Message Board Posts | Collegium Pharmaceutical Inc. (NASDAQ:COLL)
Subject | By | Source | When |
---|---|---|---|
Collegium Pharmaceutical (NASDAQ:COLL APRIL 21) - | floblu14 | investorshub | 04/21/2023 5:57:21 PM |
FWIW - Based in Stoughton, MA we are | floblu14 | investorshub | 04/12/2023 7:42:30 PM |
Collegium to Participate in 22nd Annual Needham Virtual | floblu14 | investorshub | 04/11/2023 12:06:57 PM |
Collegium Pharmaceutical management to meet with Piper Sandler | floblu14 | investorshub | 03/25/2023 11:41:44 AM |
Chronic pain patients struggle to get opioid prescriptions | floblu14 | investorshub | 03/17/2023 10:49:37 AM |
News, Short Squeeze, Breakout and More Instantly...
Collegium Pharmaceutical Inc. Company Name:
COLL Stock Symbol:
NASDAQ Market:
Collegium Pharmaceutical Inc. Website:
STOUGHTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that the U.S. Food and Drug Administrat...
2024-06-07 06:30:03 ET Jefferies analyst issues BUY recommendation for COLL on June 7, 2024 04:58AM ET. The previous analyst recommendation was Underperform. COLL was trading at $31.36 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...